INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Results

71,097 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
6
WY
Wang YanjunCCO and GC
SESea Ltd
Open-market sale · 10b5-1 plan
SELL$1,079
14 sh
Nov 5, 2026Nov 6, 2026
Page 40 of 1778
← PrevNext →
traded Nov 5, 2026
+1d
SEC Form 4

Evidence

6
WY
Wang YanjunCCO and GC
SESea Ltd
Open-market sale · 10b5-1 plan
SELL$6,538
86 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

6
WY
Wang YanjunCCO and GC
SESea Ltd
Open-market sale · 10b5-1 plan
SELL$1,896
24 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

6
WY
Wang YanjunCCO and GC
SESea Ltd
Open-market sale · 10b5-1 plan
SELL$1,876
24 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

6
WY
Wang YanjunCCO and GC
SESea Ltd
Open-market sale · 10b5-1 plan
SELL$38K
510 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

6
WY
Wang YanjunCCO and GC
SESea Ltd
Open-market sale · 10b5-1 plan
SELL$3,950
54 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

6
SS
Skates SpenserDirector, CEO and President, 10% Owner
AMPLAmplitude, Inc.
Open-market sale · 10b5-1 plan
SELL$508
29 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

6
BD
Buonasera DavidCHIEF TECHNOLOGY OFFICER
MGNIMAGNITE, INC.
Open-market sale · 10b5-1 plan
SELL$40K
1,434 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

6
MV
Magliulo VirginiaExecutive VP
ADPAUTOMATIC DATA PROCESSING INC
Option exercise · 10b5-1 plan
M$176K
852 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

6
UM
Urist MarshallEVP, Research & Investments
RPRXRoyalty Pharma plc
Derivative conversion
C—
15.0K sh
Nov 6, 2026Nov 6, 2026
traded Nov 6, 2026
+0dSEC Form 4

Evidence

6
PJ
Peters William JDirector, CFO, EVP & TREASURER
AMPHAmphastar Pharmaceuticals, Inc.
Option exercise · 10b5-1 plan
M$208K
16.0K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

5
CJ
Cheng JordanGeneral Counsel & Secretary
HAPNHappen Inc
Open-market sale · 10b5-1 plan
SELL$47K
2,800 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

5
RR
Reske James REVP/Chief Financial Officer
FCFFIRST COMMONWEALTH FINANCIAL CORP /PA/
Open-market sale · 10b5-1 plan
SELL$6,602
300 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

5
RR
Reske James REVP/Chief Financial Officer
FCFFIRST COMMONWEALTH FINANCIAL CORP /PA/
Open-market sale · 10b5-1 plan
SELL$2,186
100 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

5
RR
Reske James REVP/Chief Financial Officer
FCFFIRST COMMONWEALTH FINANCIAL CORP /PA/
Open-market sale · 10b5-1 plan
SELL$2,179
100 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

5
MD
Mansueto Joseph DDirector, Executive Chairman, 10% Owner
MORNMorningstar, Inc.
Open-market sale · 10b5-1 plan
SELL$24K
96 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

5
RR
Reske James REVP/Chief Financial Officer
FCFFIRST COMMONWEALTH FINANCIAL CORP /PA/
Open-market sale · 10b5-1 plan
SELL$3,274
150 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

5
RR
Reske James REVP/Chief Financial Officer
FCFFIRST COMMONWEALTH FINANCIAL CORP /PA/
Open-market sale · 10b5-1 plan
SELL$3,058
140 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

5
RR
Reske James REVP/Chief Financial Officer
FCFFIRST COMMONWEALTH FINANCIAL CORP /PA/
Open-market sale · 10b5-1 plan
SELL$2,178
100 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

5
HC
Hite ChristopherEVP & Chairman, Partnering
RPRXRoyalty Pharma plc
Grant or award
A—
7,122 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

5
UM
Uychiat Pison MarivicDirector
ENSGENSIGN GROUP, INC
Grant or award
A—
4,000 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

5
RR
Reske James REVP/Chief Financial Officer
FCFFIRST COMMONWEALTH FINANCIAL CORP /PA/
Open-market sale · 10b5-1 plan
SELL$4,380
200 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

5
AR
Altschuler RandolphDirector
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$35K
330 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

5
LA
Lin AlfredDirector
DASHDoorDash, Inc.
Other acquisition or disposition
J—
7.70M sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

5
LA
Lin AlfredDirector
DASHDoorDash, Inc.
Other acquisition or disposition
J—
942.2K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

5
WM
Woolsey Staci MChief Financial Officer
GVAGRANITE CONSTRUCTION INC
Tax withholding
F$23K
188 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

5
Steinert LangleyDirector, Executive Chair, 10% Owner
CARGCarGurus, Inc.
Open-market sale · 10b5-1 plan
SELL$22K
577 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

5
Steinert LangleyDirector, Executive Chair, 10% Owner
CARGCarGurus, Inc.
Open-market sale · 10b5-1 plan
SELL$8,378
224 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

5
Steinert LangleyDirector, Executive Chair, 10% Owner
CARGCarGurus, Inc.
Open-market sale · 10b5-1 plan
SELL$2,477
65 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

5
RR
Reske James REVP/Chief Financial Officer
FCFFIRST COMMONWEALTH FINANCIAL CORP /PA/
Open-market sale · 10b5-1 plan
SELL$2,194
100 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

5
RR
Reske James REVP/Chief Financial Officer
FCFFIRST COMMONWEALTH FINANCIAL CORP /PA/
Open-market sale · 10b5-1 plan
SELL$2,196
100 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

5
RR
Reske James REVP/Chief Financial Officer
FCFFIRST COMMONWEALTH FINANCIAL CORP /PA/
Open-market sale · 10b5-1 plan
SELL$2,198
100 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

5
RR
Reske James REVP/Chief Financial Officer
FCFFIRST COMMONWEALTH FINANCIAL CORP /PA/
Open-market sale · 10b5-1 plan
SELL$2,200
100 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

5
MD
Mansueto Joseph DDirector, Executive Chairman, 10% Owner
MORNMorningstar, Inc.
Open-market sale · 10b5-1 plan
SELL$19K
78 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

5
RR
Reske James REVP/Chief Financial Officer
FCFFIRST COMMONWEALTH FINANCIAL CORP /PA/
Open-market sale · 10b5-1 plan
SELL$2,185
100 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

5
RR
Reske James REVP/Chief Financial Officer
FCFFIRST COMMONWEALTH FINANCIAL CORP /PA/
Open-market sale · 10b5-1 plan
SELL$2,190
100 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

5
RR
Reske James REVP/Chief Financial Officer
FCFFIRST COMMONWEALTH FINANCIAL CORP /PA/
Open-market sale · 10b5-1 plan
SELL$2,186
100 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

5
RR
Reske James REVP/Chief Financial Officer
FCFFIRST COMMONWEALTH FINANCIAL CORP /PA/
Open-market sale · 10b5-1 plan
SELL$1,313
60 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

5
RR
Reske James REVP/Chief Financial Officer
FCFFIRST COMMONWEALTH FINANCIAL CORP /PA/
Open-market sale · 10b5-1 plan
SELL$2,187
100 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

5
RR
Reske James REVP/Chief Financial Officer
FCFFIRST COMMONWEALTH FINANCIAL CORP /PA/
Open-market sale · 10b5-1 plan
SELL$2,201
100 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence